Evidence map›Paper›PMID 42360027›Full record

ReviewAngewandte Chemie (International ed. in English)2026

Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates.

Marcell Papp, Chiara Morelli, Sarah Khawaja, Paolo Arosio

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marcell PappETH Zürich, Department of Chemical and Applied Biosciences, Institute for Chemical and Bioengineering, Zürich, Switzerland.
Chiara MorelliETH Zürich, Department of Chemical and Applied Biosciences, Institute for Chemical and Bioengineering, Zürich, Switzerland.ORCID 0000-0001-5632-888X
Sarah KhawajaETH Zürich, Department of Chemical and Applied Biosciences, Institute for Chemical and Bioengineering, Zürich, Switzerland.
Paolo ArosioETH Zürich, Department of Chemical and Applied Biosciences, Institute for Chemical and Bioengineering, Zürich, Switzerland.ORCID 0000-0002-2740-1205

Funding

European Research Council 101002094
6 · The paper itself

Abstract

Cells can form open compartments, known as biomolecular condensates, which possess distinct environments and concentrations compared to their surroundings. These biomolecular condensates can modulate biochemical processes, including protein aggregation. Notably, they have been reported to both accelerate and inhibit protein aggregation. Since protein aggregation is often associated with pathological conditions like neurodegenerative diseases, it is crucial to understand the molecular mechanisms underlying the interplay between phase separation and fibril formation. In this review, we discuss how, contrary to intuition, aggregation within the bulk of condensates can be inhibited rather than promoted, even in the presence of elevated local protein concentration. However, biomolecular condensates can still facilitate fibril formation by generating an interface between the dense and dilute phases, where molecular and mesoscale properties are optimal for the nucleation of protein aggregation.

Indexed as

AmyloidBiomolecular CondensatesHumansPhase SeparationProtein AggregatesAmyloidProtein Aggregatesamyloid formationbiomolecular condensatesinhibition and accelerationinterfaceprotein aggregation

Identifiers

PMID42360027
PMCPMC13452493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.